[HTML] springer.com

[HTML][HTML] Baseline factors associated with mortality in patients who engaged in buprenorphine treatment for opioid use disorder: a cohort study

DR Fine, L Yu, VA Triant, TP Baggett… - Journal of general internal …, 2020 - Springer
Background Opioid agonist therapy (OAT) has been shown to reduce mortality in patients
with opioid use disorder (OUD), yet mortality in individuals receiving OAT remains higher …
被引用次数：12 相关文章

Baseline Factors Associated with Mortality in Patients Who Engaged in Buprenorphine Treatment for Opioid Use Disorder: a Cohort Study

DR Fine, L Yu, VA Triant… - Journal of general …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Opioid agonist therapy (OAT) has been shown to reduce mortality in patients
with opioid use disorder (OUD), yet mortality in individuals receiving OAT remains higher …

Baseline Factors Associated with Mortality in Patients Who Engaged in Buprenorphine Treatment for Opioid Use Disorder: a Cohort Study.

DR Fine, L Yu, VA Triant, TP Baggett… - Journal of General …, 2020 - europepmc.org
Background Opioid agonist therapy (OAT) has been shown to reduce mortality in patients
with opioid use disorder (OUD), yet mortality in individuals receiving OAT remains higher …
[HTML] nih.gov

[HTML][HTML] Baseline Factors Associated with Mortality in Patients Who Engaged in Buprenorphine Treatment for Opioid Use Disorder: a Cohort Study

DR Fine, L Yu, VA Triant, TP Baggett… - Journal of General …, 2020 - ncbi.nlm.nih.gov
Background Opioid agonist therapy (OAT) has been shown to reduce mortality in patients
with opioid use disorder (OUD), yet mortality in individuals receiving OAT remains higher …

Baseline Factors Associated with Mortality in Patients Who Engaged in Buprenorphine Treatment for Opioid Use Disorder: a Cohort Study

DR Fine, L Yu, VA Triant, TP Baggett… - Journal of General …, 2020 - search.proquest.com
Background Opioid agonist therapy (OAT) has been shown to reduce mortality in patients
with opioid use disorder (OUD), yet mortality in individuals receiving OAT remains higher …

Baseline Factors Associated with Mortality in Patients Who Engaged in Buprenorphine Treatment for Opioid Use Disorder: a Cohort Study.

DR Fine, L Yu, VA Triant, TP Baggett… - JGIM: Journal of …, 2020 - search.ebscohost.com
Background: Opioid agonist therapy (OAT) has been shown to reduce mortality in patients
with opioid use disorder (OUD), yet mortality in individuals receiving OAT remains higher …